Physician profile
Mark S Miller
NPI 1427048313
$1,484.65
in general payments reported to CMS, 2019-2025
10 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2021: $246 · 2022: $167 · 2023: $352 · 2024: $125 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Travel and Lodging: $36.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.79 |
| Travel and Lodging | $36.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $316.94 | 2019-2023 | Puraply Antimicrobial, Puraply |
| Nevro Corp. | $222.21 | 2023 | Senza |
| Stryker Corporation | $162.14 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aroa Biosurgery Incorporated | $134.26 | 2025 | |
| Trimed, INC. | $125.00 | 2024 | |
| Horizon Therapeutics Plc | $124.51 | 2021 | |
| Advanced Oxygen Therapy INC. | $121.12 | 2021 | |
| Grt US Holding, INC. | $104.41 | 2022 | |
| Melinta Therapeutics, LLC | $98.38 | 2019 | |
| Medtronic Vascular, INC. | $75.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.